The effect of low dose aspirin on platelet inhibition in patients with rheumatoid arthritis
Phase 1
- Conditions
- Condition 1: Rheumatoid arthritis. Condition 2: Rheumatoid arthritis.Rheumatoid arthritis, unspecified
- Registration Number
- IRCT201707293812N6
- Lead Sponsor
- Connective Tissue research Center- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Patients with rheumatoid arthritis who have been diagnosed with EULAR 2010 ACR criteria and have been ill for 6 months
Exclusion criteria:
Includes recent use of aspirin and anti-coagulant drugs, history of aspirin allergy, renal failure (creatinine above 8.1 mg / dL), thrombotic cytopenia, pregnancy, gastric ulcer and gastrointestinal bleeding. Patients with maternal and metabolic disorders are also among the exclusion criteria.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet aggregation. Timepoint: One week. Method of measurement: Elisa.
- Secondary Outcome Measures
Name Time Method TXA2. Timepoint: one weak. Method of measurement: Elisa.;TX-A2. Timepoint: One week. Method of measurement: Elisa.